We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Bad science

6 January 2009 By John Foley

It s no shock that the chemicals firm has buckled under $26bn of debt it can no longer service. That s what happens to overleveraged cyclical companies in a downturn. But the speed and intensity of Lyondell’s meltdown bodes ill for other troubled deals.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)